Timtraxanib is a small molecule containing aromatic, heterocyclic, and polar groups arranged for controlled conformational flexibility. Researchers use it to study ligand docking, electronic distribution, and intermolecular interactions. Its modular scaffold supports structure-activity evaluation. The compound's design aids mechanistic chemical biology studies.
CAT No: R2302
CAS No:2412172-33-7
Synonyms/Alias:timtraxanib;Timtraxanib [INN];N-Ac-Arg-Leu-Tyr-Glu;FA3HNX7HP6;2412172-33-7;L-Glutamic acid, N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-;UNII-FA3HNX7HP6;AVI3207;AVI-3207;AKOS040757720;DA-78483;N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-L-glutamic acid;
Timtraxanib is a synthetic carbohydrate compound recognized for its unique molecular architecture and versatile functional properties, making it highly valuable in advanced research and development contexts. Engineered to mimic specific glycan structures, Timtraxanib offers researchers a reliable tool for probing carbohydrate-mediated biological processes and facilitating the design of novel biomolecular systems. Its solubility and stability under a variety of laboratory conditions enable seamless integration into a broad spectrum of experimental workflows, further enhancing its appeal in both academic and industrial settings. As a result, Timtraxanib is increasingly sought after for projects that demand precise glycoscience interventions and innovative analytical approaches.
Glycobiology Research: In the field of glycobiology, Timtraxanib serves as an essential probe for elucidating carbohydrate-protein interactions. Researchers utilize this compound to investigate the binding affinities and specificities of lectins, enzymes, and other glycan-recognizing proteins. By incorporating Timtraxanib into binding assays or structural studies, scientists can gain deeper insights into the mechanisms underlying cell signaling, pathogen recognition, and immune modulation. Its well-defined structure allows for reproducible experiments, facilitating the mapping of glycan-binding domains and the identification of new therapeutic targets within complex biological systems.
Drug Discovery and Development: For drug discovery initiatives, Timtraxanib is employed as a model glycan to screen for potential inhibitors or modulators of carbohydrate-binding proteins. Its role in high-throughput screening platforms enables the identification of lead compounds that can disrupt or enhance specific glycan-mediated pathways. By simulating key carbohydrate motifs found in nature, Timtraxanib supports the rational design of small molecules or biologics with improved selectivity and efficacy. This application is particularly valuable in the search for agents targeting infectious diseases, cancer, and autoimmune conditions where glycan interactions play a pivotal role.
Vaccine Design and Antigen Presentation: Timtraxanib contributes to the development of next-generation vaccines by acting as a glycan antigen or adjuvant component. Researchers incorporate this compound into synthetic vaccine constructs to mimic pathogen-associated carbohydrate patterns, thereby enhancing immune recognition and response. Its use in antigen presentation studies helps clarify how the immune system differentiates between self and non-self glycans, guiding the optimization of vaccine formulations for increased immunogenicity. By leveraging Timtraxanib's structural fidelity, scientists can systematically evaluate the impact of glycan modifications on vaccine efficacy and safety.
Analytical Method Development: Analytical chemists rely on Timtraxanib as a calibration standard or reference material in the development and validation of carbohydrate detection techniques. Its consistent quality and defined molecular features make it ideal for optimizing chromatographic, spectrometric, or immunoassay-based methods. By integrating Timtraxanib into these workflows, laboratories can ensure accurate quantification and characterization of complex glycan mixtures in biological or pharmaceutical samples. This application streamlines quality control processes and supports the advancement of analytical technologies tailored to glycoscience research.
Biomaterials Engineering: In the realm of biomaterials science, Timtraxanib is utilized to modify surfaces and scaffolds with specific carbohydrate motifs, thereby influencing cell adhesion, proliferation, and differentiation. Its incorporation into hydrogels, nanoparticles, or coatings enables the creation of bioactive materials that mimic natural extracellular matrices or target particular cell types. By harnessing the biological activity of Timtraxanib, engineers can design functional materials for regenerative medicine, tissue engineering, and targeted delivery systems. This approach opens new avenues for the customization of biomaterials with finely tuned biological properties, ultimately enhancing their performance in research and therapeutic applications.
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More